IL4 and obesity disorder: Based on these data, we propose that, during obesity, reduced AT-EOS content is accompanied by decreased IL-4 levels, and this adversely affects adipocyte leptin secretion, thereby contributing to development of hyperleptinemia and leptin resistance.